Ariad Pharmaceuticals, Inc. Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of three senior executives to ARIAD’s management team in newly created positions: Daniel M. Bollag, Ph.D. as senior vice president, regulatory affairs and quality, Andreas Woppmann, Ph.D. as vice president, manufacturing operations and Kelly M. Schmitz as vice president, information technology and operations.